Immunovant, Inc. IMVT FX Effect on Cash
FX Effect on Cash at other companies
Other financials
Where this comes from
Reported directly by Immunovant, Inc. in its filing.
Tagged under the XBRL concept us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents.
The official record: Immunovant, Inc.’s 10-K, filed May 20, 2026, on SEC EDGAR. View the filing →
Ask your AI about Immunovant, Inc.'s fx effect on cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Immunovant, Inc.'s FX effect on cash?
- Immunovant, Inc. (IMVT) reported FX effect on cash of -$988K in Q1 2026.
- What is the long-term trend for Immunovant, Inc.'s FX effect on cash?
- Over 2 years (2022 to 2026), Immunovant, Inc.'s FX effect on cash has grown at a 80.3% compound annual growth rate (CAGR), from -$92K to -$299K.
- What does FX effect on cash mean?
- The impact of exchange rate changes on the value of cash and equivalents held in foreign currencies.